BG Medicine files for $80 mln IPO
WASHINGTON Aug 3 (Reuters) - BG Medicine Inc., a life sciences company, on Friday said it plans an initial public offering of as much as $80 million.
Cowen International Limited, Fortis and Leerink Swann & Company will underwrite the IPO, according to a preliminary offering document filed with the U.S. Securities and Exchange Commission.
The company said it is seeking to list its shares on Euronext Amsterdam by NYSE Euronext under the symbol "BGMDX." (Reporting by John Poirier)